Infliximab in the treatment of recalcitrant idiopathic orbital inflammation

Ophthalmic Plastic and Reconstructive Surgery

Volumn 20, Issue 5, 2004, Pages 381-383

  Wilson, Matthew W ^a,c   Shergy, William J ^b   Haik, Barren G ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Rheumatology Associates of North Alabama   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; INFLIXIMAB; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ANAMNESIS; ARTICLE; BEAM THERAPY; CASE REPORT; CLINICAL FEATURE; DRUG RESPONSE; ENZYME BLOOD LEVEL; HUMAN; INTRAOCULAR HYPERTENSION; MALE; MYOSITIS; ORBIT PSEUDOTUMOR; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TREATMENT FAILURE; WEIGHT GAIN;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644307790     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000139521.38345.BA     Document Type: Article

References (9)

1. Ahn Yuen SJ. Rubin PAD. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003;121:491-9.
2. Mombaerts I, Koornneef L. Current status in the treatment of orbital myositis. Ophthalmology 1997;104:402-8.
3. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;45:252-7.
4. Joseph A, Raj D, Dua HS, et al. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 2003;110:1449-53.
5. Maini RN, Elliott M, Brennan FM, et al. Targeting TNF alpha for therapy of rheumatoid arthritis. Clin Exp Rheumatol 1994;12(Suppl 11):S63-6.
6. Nahar IK, Shojania K, Marra CA, et al. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother 2003;37:1256-65.
7. Brandt J, Haibel H, Cornely D, et al. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis alpha monoclonal antibody infliximab. Arthritis Rheum 2000;43:1346-52.
8. Lipsky PE, van der Heijde DM, St. Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis: Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;30:1594-602.
9. Cheifetz A, Smedley M, Martin S, et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 2003;98:1315-24.